0.05 (1.462%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Weak
GARP
Weak
MQV Small
Very Weak
Valuation
Value
Consensus
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
N/A
Telephone
61.13.0045.3688
Address
1868-1892 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.14 - 3.86
Trade Value (12mth)
AU$850,801.00
1 week
0%
1 month
-5.52%
YTD
15.93%
1 year
34.12%
All time high
6.39
EPS 3 yr Growth
-69.70%
EBITDA Margin
26.90%
Operating Cashflow
$160m
Free Cash Flow Return
41.50%
ROIC
6.20%
Interest Coverage
10.90
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
199m
HALO Sector
Healthcare
Next Company Report Date
21-Aug-25
Ex Dividend Date (est.)
04-Sep-24
Next Dividend Pay Date (est.)
27-Sep-24
Reporting Currency
AUD
Short Sell (% of issue)
0.87
| Date | Announcements |
|---|---|
|
21 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
20 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
19 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
19 November 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
18 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
18 November 24 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
18 November 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
18 November 24 |
Ceasing to be a substantial holder from CBA
×
Ceasing to be a substantial holder from CBA |
|
15 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
15 November 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
14 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
13 November 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
06 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
05 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
04 November 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
04 November 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
01 November 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
|
01 November 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
31 October 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
30 October 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
29 October 24 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
29 October 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
|
29 October 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
|
29 October 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
29 October 24 |
Becoming a substantial holder from CBA
×
Becoming a substantial holder from CBA |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
